BEGAM, a new apparatus for the identification of β emitter contaminants in radiopharmaceuticals


Published: May 31, 2025
Keywords:
Radiopharmaceuticals scintillator detectors gamma ray - spectroscopy b-tagging
Marco Perri
Adriana Nannini
Giovanni Casini
Silvia Piantelli
Giulia Nicastro
Alessandro Passeri
Paola Saletti
Abstract
The BEGAM project aims at developing a portable detector capable of performing γ/β coincidence and anti-coincidence measurements to estimate the presence of long-lived β-contaminants in radiopharmaceutical solutions. A preliminary prototype of the apparatus is under construction. It is composed of four sectors of Caesium Iodide (CsI) scintillators surrounding a cylindrical plastic scintillator. The scintillation readout is performed via silicon photomultiplier (SiPM) and after some preamplification the signals are sent to a commercial digitizer. Geant4 simulations of the detector's response have been developed and validated using gamma and electron sources. Preliminary γ/β coincidence measurements from a 207Bi source have been performed. Near-future plans include testing the BEGAM detector to estimate the activity of 99Mo contaminants in 99mTc solutions.
Article Details
  • Section
  • Oral contributions
References
S. Zhang, et al., Signal Transduct. Target. Ther. 10, 1 (2025); doi: 10.1038/s41392-024-02041-6
J. Steigman, et al., Sem. Nucl. Med. 4, 269 (1974); doi: 10.1016/S0001-2998(74)80014-0
D. Bars, J. Fluor. Chem. 127, 1488 (2006); doi: 10.1016/j.jfluchem.2006.09.015
E. Akgun, Fabad Journal of Pharmaceutical Sciences 46, 93 (2021)
D. Soloviev et al., Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [18F]Fluorodeoxyglucose (FDG), IAEA (2012)
Non-HEU Production Technologies for Molybdenum-99 and Technetium-99m, IAEA Nuclear Energy Series (2013)